Generalized anxiety disorder. Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: having diagnosed of GAD based on semi structured interview. Regarding the high co morbidity of GAD with other disorder, patient selected that have the primary diagnose of GAD; minimum level of the third grade of primary school. Exclusion criteria: having severe personality disorder; having the diagnose of psychotic or bipolar disorder; currently use of psychotherapy or medication; having the history of psychotherapy before the research; having disabling somatic decease; alcohol or substance addiction.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GAD sign and symptom. Timepoint: pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: GAD-7 questionnare.;Worry. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: PSWQ.;Cognitive avoidance. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: CAQ.;Emotion regulation. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: DERS.;Quality of life. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: WHO- QOL- BREF.;Mindfulness attention. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: MAAS.;Self compassion. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: SCS.;Beliefs about worry. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: wwq-II.;Problem solving. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: PSI.;Relationship with child. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: CPRS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University